...
首页> 外文期刊>Bone marrow transplantation >Severe acute graft-versus-host disease occurring after syngeneic BMT for AML in a patient not given prior cyclosporin A therapy.
【24h】

Severe acute graft-versus-host disease occurring after syngeneic BMT for AML in a patient not given prior cyclosporin A therapy.

机译:在未接受环孢菌素A治疗的患者中,发生AML的同种BMT后发生严重的急性移植物抗宿主病。

获取原文
获取原文并翻译 | 示例

摘要

A syndrome akin to graft-versus-host disease in the recipient of syngeneic stem cells is hitherto described as being milder, self-limiting and confined to the skin. It is enhanced by prior cyclosporin A therapy. We describe here a recipient of a syngeneic marrow transplant who did not receive priming with cyclosporin A and yet developed severe and progressive graft-versus-host disease which necessitated and responded to high-dose immunosuppressive therapy. We believe that this is because the conditioning regimen in stem cell transplant acts to reset the immune system enabling it to recognise 'self' antigens. Bone Marrow Transplantation (2000) 25, 205-207.
机译:迄今为止,同基因干细胞受体中的一种类似于移植物抗宿主病的综合征被描述为较温和,自限性且仅限于皮肤。通过先前的环孢菌素A疗法可以增强它。我们在这里描述了同基因骨髓移植的接受者,该接受者未接受环孢菌素A的启动作用,但发展为严重且进行性的移植物抗宿主病,必须对大剂量免疫抑制疗法作出反应。我们认为这是因为干细胞移植中的调节方案可重置免疫系统,使其能够识别“自身”抗原。骨髓移植(2000)25,205-207。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号